Key facts
- Notable investors include Zizhu Xiaomiao PE, Leaguer Financial.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Dipushenhe
- ·The full record, as it builds
Funding rounds
No funding rounds for Dipushenhe are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dipushenhe
Developer of simulation models designed for specific drug development scenarios. The company's service plays the role of AI data base, providing clients with customized experiments and final training model will provide better effect than using traditional methods.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Dipushenhe doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dipushenhe shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dipushenhe in its N-PORT filings yet. We sweep new filings monthly.